NCT01536626View on ClinicalTrials.gov

Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

CompletedOBSERVATIONAL

Enrollment

211

Participants

Timeline

Start Date

June 9, 2006

Primary Completion Date

April 10, 2007

Study Completion Date

April 10, 2007

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Prescription at the discretion of the treating physician

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Alphen aan den Rijn

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY